Video Experimental Relacionado
Updated: Aug 9, 2025
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.1K
Características de las enfermedades neurodegenerativas
David M Wilson1, Mark R Cookson2, Ludo Van Den Bosch3
1Hasselt University, Biomedical Research Institute, BIOMED, 3500 Hasselt, Belgium.
Cell
|February 21, 2023
Resumen
Este estudio describe ocho características clave de las enfermedades neurodegenerativas (NDD), ofreciendo un marco holístico para comprender sus mecanismos. Este enfoque tiene como objetivo mejorar la estratificación del paciente y personalizar las terapias para un tratamiento eficaz de NDD.
Área de la Ciencia:
- La neurociencia
- La genética
- La bioquímica
Sus antecedentes:
- Las enfermedades neurodegenerativas (NDD) implican vías genéticas y bioquímicas complejas.
- La investigación existente ha identificado numerosos factores que contribuyen a los NDD.
Objetivo del estudio:
- Presentar un marco unificador de las ocho características principales de los NDD.
- Establecer una base para la comprensión de la patogénesis, clasificación y tratamiento de la NDD.
Principales métodos:
- Revisión de la literatura y síntesis de las investigaciones existentes sobre los NDD.
- Identificación y descripción de ocho características clave y sus biomarcadores.
Principales resultados:
- Se identificaron ocho características de los NDD: agregación de proteínas, disfunción sináptica, desequilibrio de la proteostasis, problemas citosqueléticos, defectos del metabolismo energético, daño al ADN / ARN, inflamación y muerte celular.
- Se describen las interacciones entre estas características.
- Se discuten los biomarcadores para cada marca.
Conclusiones:
- Un marco holístico basado en ocho características puede avanzar en la investigación de NDD.
- Este marco apoya la definición de los mecanismos patógenos y la categorización de los NDD.
- Facilita la estratificación del paciente y el diseño de terapias personalizadas y multidireccionales para NDD.
Videos de Conceptos Relacionados
01:26Alzheimer's Disease: Overview
591
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
591
01:15Parkinson's Disease: Overview
639
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
639
01:37Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
01:22Alzheimer's Disease: Treatment
235
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
235
03:03Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
01:30Dementia
151
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
151